LCTX logo

Lineage Cell Therapeutics, Inc. (LCTX)

Profile

Full Name

Lineage Cell Therapeutics, Inc.

Ticker

NYSEAmerican: LCTX

Exchange

NYSE American

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 5, 1992

Indexes

Not included

Website

https://www.lineagecell.com

Employees

70

Key Details

Price

$1.17(-3.31%)

Market cap

$267.18M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$9.50M(+6.19% YoY)

Annual EPS

-$0.09(+25.00% YoY)

PE ratio

-

Next earnings date

Nov 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.17
    LCTX price is $1.17

    30-Day Relative Volume

    0.62
    LCTX 30-day relative volume is 0.62

    Price Performance

    Price Most recent change

    -3.31%
    LCTX price was down -3.31% on Aug 29, 2025

    Price YTD change

    +134%
    LCTX price is up +134% since January 1st

    Price 1-year change

    +32.95%
    LCTX price is up +32.95% year-on-year

    Price 3-year change

    -18.18%
    LCTX price is down -18.18% over the past 3 years

    Price Range

    Price All-time high

    $27.00
    LCTX price is currently -95.67% below its historical high of $27.00

    Price 3-year low

    $0.37
    LCTX price is currently +216.22% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $267.18M
    LCTX market capitalization is $267.18 million

    Market cap 3-year change

    +10.06%
    LCTX market capitalization is up +10.06% over the past 3 years

    Market cap All-time high

    $486.42M
    LCTX market capitalization is currently -45.07% below its historical high of $486.42 million

    Market cap sector rank

    55.8%
    LCTX market capitalization is higher than 55.8% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +20.93%
    LCTX shares outstanding is up +20.93% year-on-year

    Shares Outstanding 3-Year Change

    +34.52%
    LCTX shares outstanding is up +34.52% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.92
    LCTX beta is 0.92

    200-day SMA

    $0.70
    LCTX price is currently +67.74% above its 200-day simple moving average

    50-day SMA

    $1.05
    LCTX price is currently +11.15% above its 50-day simple moving average

    RSI

    55.50
    LCTX 14-day relative strength index is 55.50

    Volume

    0.62
    LCTX 30-day relative volume is 0.62

    ATR

    $0.08
    LCTX average true range is $0.08

    10-day Historical Volatility

    64.81%
    LCTX 10-day historical volatility is 64.81%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $9.50M
    LCTX annual revenue is $9.50 million

    Revenue Analysts estimate

    $8.63M
    LCTX annual revenue is currently +10.01% higher than the consensus analysts' forecast

    Revenue 1-year change

    +6.19%
    LCTX annual revenue is up +6.19% year-on-year

    Revenue Sector rank

    47.49%
    LCTX annual revenue is higher than 47.49% of companies in Healthcare sector

    EPS

    EPS

    -$0.09
    LCTX annual earnings per share is -$0.09

    EPS Analysts estimate

    -$0.19
    LCTX annual earnings per share is currently -53.05% lower than the consensus analysts' forecast

    EPS 1-year change

    +25%
    LCTX annual earnings per share is up +25% year-on-year

    EPS Sector rank

    73.67%
    LCTX annual earnings per share is higher than 73.67% of companies in Healthcare sector

    Profit

    Gross profit

    $8.56M
    LCTX annual gross profit is $8.56 million

    Gross margin

    90.07%
    LCTX annual gross profit margin is 90.07%

    Operating profit

    -$21.48M
    LCTX annual operating income is -$21.48 million

    Operating margin

    -226.11%
    LCTX annual operating profit margin is -226.11%

    Net income

    -$18.58M
    LCTX annual net profit is -$18.58 million

    Net margin

    -195.62%
    LCTX annual net profit margin is -195.62%

    Expenses

    Total expenses

    $30.98M
    LCTX annual total expenses is $30.98 million

    Operating expenses

    $30.64M
    LCTX annual total operating expenses is $30.64 million

    Cost of goods sold

    $943.00K
    LCTX annual cost of goods sold is $943.00 thousand

    Selling, general & administrative expenses

    $18.17M
    LCTX annual SGA is $18.17 million

    Depreciation and amortization

    $609.00K
    LCTX annual depreciation & amortization is $609.00 thousand

    Interest expense

    $0.00
    LCTX annual interest expense is $0.00

    Income tax

    $0.00
    LCTX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$21.48M
    LCTX annual earnings before interest & taxes is -$21.48 million

    EBITDA

    -$20.87M
    LCTX annual EBITDA is -$20.87 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $113.22M
    LCTX annual total assets is $113.22 million

    Non current assets

    $62.22M
    LCTX annual long term assets is $62.22 million

    Current assets

    $51.00M
    LCTX annual total current assets is $51.00 million

    Cash and cash equivalents

    $45.79M
    LCTX annual cash & cash equivalents is $45.79 million

    Accounts receivable

    $638.00K
    LCTX annual accounts receivable is $638.00 thousand

    Inventory

    $0.00
    LCTX annual inventory is $0.00

    Liabilities

    Total liabilities

    $36.21M
    LCTX annual total liabilities is $36.21 million

    Long term liabilities

    $20.87M
    LCTX annual total long term liabilities is $20.87 million

    Current liabilities

    $13.98M
    LCTX annual total current liabilities is $13.98 million

    Accounts payable

    $1.17M
    LCTX annual accounts payable is $1.17 million

    Debt

    Total debt

    $2.51M
    LCTX annual total debt is $2.51 million

    Total debt 1-year change

    -14.84%
    LCTX annual total debt is down -14.84% year-on-year

    Long term debt

    $1.36M
    LCTX annual long term debt is $1.36 million

    Short term debt

    $1.15M
    LCTX annual short term debt is $1.15 million

    Equity & Capital

    Shareholders equity

    $78.38M
    LCTX annual stockholders equity is $78.38 million

    Book value

    $78.38M
    LCTX annual book value is $78.38 million

    Retained earnings

    -$403.46M
    LCTX annual retained earnings is -$403.46 million

    Working capital

    $37.02M
    LCTX annual working capital is $37.02 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$23.09M
    LCTX annual cash flow from operations is -$23.09 million

    Cash from operations 1-year change

    +19.16%
    LCTX annual cash flow from operations is up +19.16% year-on-year

    Cash from investing

    -$2.31M
    LCTX annual cash flow from investing activities is -$2.31 million

    Cash from investing 1-year change

    -104.97%
    LCTX annual cash flow from investing activities is down -104.97% year-on-year

    Cash from financing

    $35.86M
    LCTX annual cash flow from financing activities is $35.86 million

    Cash from financing 1-year change

    +458.26%
    LCTX annual cash flow from financing activities is up +458.26% year-on-year

    CAPEX

    CAPEX

    $565.00K
    LCTX annual capital expenditures is $565.00 thousand

    CAPEX 1-year change

    -16.17%
    LCTX annual capital expenditures is down -16.17% year-on-year

    Free Cash Flow

    Free cash flow

    -$23.66M
    LCTX annual free cash flow is -$23.66 million

    Free cash flow 1-year change

    +19.09%
    LCTX annual free cash flow is up +19.09% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    90.07%
    LCTX annual gross profit margin is 90.07%

    Operating margin

    -226.11%
    LCTX annual operating profit margin is -226.11%

    Net margin

    -195.62%
    LCTX annual net profit margin is -195.62%

    ROA & ROE

    ROA

    -17.35%
    LCTX annual return on assets is -17.35%

    ROE

    -26.73%
    LCTX annual return on equity is -26.73%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    LCTX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    LCTX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    5.52
    LCTX price to book ratio is 5.52

    PB ratio Sector rank

    80.47%
    LCTX price to book ratio is higher than 80.47% of companies in Healthcare sector

    PS Ratio

    PS ratio

    24.48
    LCTX price to sales ratio is 24.48

    PS ratio Sector rank

    82.94%
    LCTX price to sales ratio is higher than 82.94% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $227.04M
    LCTX enterprise value is $227.04 million

    Enterprise value Sector rank

    57.71%
    LCTX enterprise value is higher than 57.71% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -11.49
    LCTX EV/EBITDA is -11.49

    EV/EBITDA Sector rank

    11.06%
    LCTX EV/EBITDA is higher than 11.06% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.65
    LCTX annual current ratio is 3.65

    Quick ratio

    3.65
    LCTX annual quick ratio is 3.65

    Leverage

    Debt to equity

    0.00
    LCTX annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    LCTX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    5
    LCTX piotroski f-score is 5

    Altman Z-Score

    -0.71
    LCTX altman z-score is -0.71

    Analyst ratings

    Recent major analysts updates

    Aug 27, 25 D. Boral Capital
    Buy
    Aug 14, 25 D. Boral Capital
    Buy
    Aug 5, 25 D. Boral Capital
    Buy
    Jun 23, 25 HC Wainwright & Co.
    Buy
    Jun 23, 25 D. Boral Capital
    Buy
    Mar 14, 25 B. Riley Securities
    Buy
    Mar 11, 25 HC Wainwright & Co.
    Buy
    Mar 11, 25 D. Boral Capital
    Buy
    Feb 11, 25 HC Wainwright & Co.
    Buy
    Feb 11, 25 D. Boral Capital
    Buy

    Institutional Ownership

    Screeners with LCTX included

    Growing Shares Outstanding
    US stocks
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Biotech Companies
    Best performing stocks YTD
    • What is the ticker symbol for Lineage Cell Therapeutics, Inc.?
    • Does Lineage Cell Therapeutics, Inc. pay dividends?
    • What sector is Lineage Cell Therapeutics, Inc. in?
    • What industry is Lineage Cell Therapeutics, Inc. in?
    • What country is Lineage Cell Therapeutics, Inc. based in?
    • When did Lineage Cell Therapeutics, Inc. go public?
    • Is Lineage Cell Therapeutics, Inc. in the S&P 500?
    • Is Lineage Cell Therapeutics, Inc. in the NASDAQ 100?
    • Is Lineage Cell Therapeutics, Inc. in the Dow Jones?
    • When was Lineage Cell Therapeutics, Inc.'s last earnings report?
    • When does Lineage Cell Therapeutics, Inc. report earnings?

    What is the ticker symbol for Lineage Cell Therapeutics, Inc.?

    The ticker symbol for Lineage Cell Therapeutics, Inc. is NYSEAmerican:LCTX

    Does Lineage Cell Therapeutics, Inc. pay dividends?

    No, Lineage Cell Therapeutics, Inc. does not pay dividends

    What sector is Lineage Cell Therapeutics, Inc. in?

    Lineage Cell Therapeutics, Inc. is in the Healthcare sector

    What industry is Lineage Cell Therapeutics, Inc. in?

    Lineage Cell Therapeutics, Inc. is in the Biotechnology industry

    What country is Lineage Cell Therapeutics, Inc. based in?

    Lineage Cell Therapeutics, Inc. is headquartered in United States

    When did Lineage Cell Therapeutics, Inc. go public?

    Lineage Cell Therapeutics, Inc.'s initial public offering (IPO) was on March 5, 1992

    Is Lineage Cell Therapeutics, Inc. in the S&P 500?

    No, Lineage Cell Therapeutics, Inc. is not included in the S&P 500 index

    Is Lineage Cell Therapeutics, Inc. in the NASDAQ 100?

    No, Lineage Cell Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Lineage Cell Therapeutics, Inc. in the Dow Jones?

    No, Lineage Cell Therapeutics, Inc. is not included in the Dow Jones index

    When was Lineage Cell Therapeutics, Inc.'s last earnings report?

    Lineage Cell Therapeutics, Inc.'s most recent earnings report was on August 12, 2025

    When does Lineage Cell Therapeutics, Inc. report earnings?

    The next expected earnings date for Lineage Cell Therapeutics, Inc. is November 13, 2025
    On this page